A Chinese pharmaceutical company expects to hire up to 500 employees for the first phase of its new campus in northern ...
NAMSA recently announced plans to acquire WuXi AppTec’s medical device testing operations in the U.S. As part of the ...
WuXi Biologics is expected to deliver faster sales growth and higher margins this year. Click here to find out why I upgraded ...
At the JP Morgan Conference 2025, CEO Chen said the potential of the Biosecure Act passing has had only a minimal chilling ...
Exploring the natural beauty of Taihu Lake and penning the Chinese character "fu" for good fortune, a group of international ...
CMB International Securities analyst Jill Wu has maintained their bullish stance on WXIBF stock, giving a Buy rating on January 13.Stay Ahead ...
WuXi AppTec is parting ways with its U.S. medical device testing business, selling its two stateside locations to the Ohio-based regulatory consulting firm NAMSA. | The deal includes facilities in ...
"We are thrilled to join forces with Roundtree Lab to deliver AI-powered medical transport beds to the U.S. healthcare market. This collaboration underscores our dedication to creating cutting-edge ...